世界のアポモルヒネ塩酸塩注射液市場予測2023-2029:ペン型注射器、輸液ポンプ

【英語タイトル】Apomorphine Hydrochloride Injection Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23JU5014)・商品コード:MMG23JU5014
・発行会社(調査会社):Market Monitor Global
・発行日:2023年6月
・ページ数:77
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医療機器&消耗品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のアポモルヒネ塩酸塩注射液市場規模と予測を収録しています。・世界のアポモルヒネ塩酸塩注射液市場:売上、2018年-2023年、2024年-2029年
・世界のアポモルヒネ塩酸塩注射液市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のアポモルヒネ塩酸塩注射液市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ペン型注射器」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

アポモルヒネ塩酸塩注射液のグローバル主要企業は、Supernus Pharmaceuticals、 Britannia Pharmaceuticals STADA、 Ever Pharma、 Evolan Pharma AB (PharmSwed)などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、アポモルヒネ塩酸塩注射液のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のアポモルヒネ塩酸塩注射液市場:タイプ別、2018年-2023年、2024年-2029年
世界のアポモルヒネ塩酸塩注射液市場:タイプ別市場シェア、2022年
・ペン型注射器、輸液ポンプ

世界のアポモルヒネ塩酸塩注射液市場:用途別、2018年-2023年、2024年-2029年
世界のアポモルヒネ塩酸塩注射液市場:用途別市場シェア、2022年
・パーキンソン病、勃起不全

世界のアポモルヒネ塩酸塩注射液市場:地域・国別、2018年-2023年、2024年-2029年
世界のアポモルヒネ塩酸塩注射液市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるアポモルヒネ塩酸塩注射液のグローバル売上、2018年-2023年
・主要企業におけるアポモルヒネ塩酸塩注射液のグローバル売上シェア、2022年
・主要企業におけるアポモルヒネ塩酸塩注射液のグローバル販売量、2018年-2023年
・主要企業におけるアポモルヒネ塩酸塩注射液のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Supernus Pharmaceuticals、 Britannia Pharmaceuticals STADA、 Ever Pharma、 Evolan Pharma AB (PharmSwed)

*************************************************************

・調査・分析レポートの概要
アポモルヒネ塩酸塩注射液市場の定義
市場セグメント
世界のアポモルヒネ塩酸塩注射液市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のアポモルヒネ塩酸塩注射液市場規模
世界のアポモルヒネ塩酸塩注射液市場規模:2022年 VS 2029年
世界のアポモルヒネ塩酸塩注射液市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのアポモルヒネ塩酸塩注射液の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のアポモルヒネ塩酸塩注射液製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:ペン型注射器、輸液ポンプ
アポモルヒネ塩酸塩注射液のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:パーキンソン病、勃起不全
アポモルヒネ塩酸塩注射液の用途別グローバル売上・予測

・地域別市場分析
地域別アポモルヒネ塩酸塩注射液市場規模 2022年と2029年
地域別アポモルヒネ塩酸塩注射液売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Supernus Pharmaceuticals、 Britannia Pharmaceuticals STADA、 Ever Pharma、 Evolan Pharma AB (PharmSwed)
...

Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
This report aims to provide a comprehensive presentation of the global market for Apomorphine Hydrochloride Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Apomorphine Hydrochloride Injection. This report contains market size and forecasts of Apomorphine Hydrochloride Injection in global, including the following market information:
Global Apomorphine Hydrochloride Injection Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Apomorphine Hydrochloride Injection Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Apomorphine Hydrochloride Injection companies in 2022 (%)
The global Apomorphine Hydrochloride Injection market was valued at US$ 256.2 million in 2022 and is projected to reach US$ 331.1 million by 2029, at a CAGR of 3.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025.
Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.
Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%.
Market competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Apomorphine Hydrochloride Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Apomorphine Hydrochloride Injection Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Apomorphine Hydrochloride Injection Market Segment Percentages, by Type, 2022 (%)
Pen Injectors
Infusion Pumps
Global Apomorphine Hydrochloride Injection Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Apomorphine Hydrochloride Injection Market Segment Percentages, by Application, 2022 (%)
Parkinson Disease
Erectile Dysfunction
Global Apomorphine Hydrochloride Injection Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Apomorphine Hydrochloride Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Apomorphine Hydrochloride Injection revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Apomorphine Hydrochloride Injection revenues share in global market, 2022 (%)
Key companies Apomorphine Hydrochloride Injection sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Apomorphine Hydrochloride Injection sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Apomorphine Hydrochloride Injection, market overview.
Chapter 2: Global Apomorphine Hydrochloride Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Apomorphine Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Apomorphine Hydrochloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Apomorphine Hydrochloride Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Apomorphine Hydrochloride Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Apomorphine Hydrochloride Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Apomorphine Hydrochloride Injection Overall Market Size
2.1 Global Apomorphine Hydrochloride Injection Market Size: 2022 VS 2029
2.2 Global Apomorphine Hydrochloride Injection Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Apomorphine Hydrochloride Injection Sales: 2018-2029
3 Company Landscape
3.1 Top Apomorphine Hydrochloride Injection Players in Global Market
3.2 Top Global Apomorphine Hydrochloride Injection Companies Ranked by Revenue
3.3 Global Apomorphine Hydrochloride Injection Revenue by Companies
3.4 Global Apomorphine Hydrochloride Injection Sales by Companies
3.5 Global Apomorphine Hydrochloride Injection Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Apomorphine Hydrochloride Injection Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Apomorphine Hydrochloride Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Apomorphine Hydrochloride Injection Players in Global Market
3.8.1 List of Global Tier 1 Apomorphine Hydrochloride Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Apomorphine Hydrochloride Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Apomorphine Hydrochloride Injection Market Size Markets, 2022 & 2029
4.1.2 Pen Injectors
4.1.3 Infusion Pumps
4.2 By Type – Global Apomorphine Hydrochloride Injection Revenue & Forecasts
4.2.1 By Type – Global Apomorphine Hydrochloride Injection Revenue, 2018-2023
4.2.2 By Type – Global Apomorphine Hydrochloride Injection Revenue, 2024-2029
4.2.3 By Type – Global Apomorphine Hydrochloride Injection Revenue Market Share, 2018-2029
4.3 By Type – Global Apomorphine Hydrochloride Injection Sales & Forecasts
4.3.1 By Type – Global Apomorphine Hydrochloride Injection Sales, 2018-2023
4.3.2 By Type – Global Apomorphine Hydrochloride Injection Sales, 2024-2029
4.3.3 By Type – Global Apomorphine Hydrochloride Injection Sales Market Share, 2018-2029
4.4 By Type – Global Apomorphine Hydrochloride Injection Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Apomorphine Hydrochloride Injection Market Size, 2022 & 2029
5.1.2 Parkinson Disease
5.1.3 Erectile Dysfunction
5.2 By Application – Global Apomorphine Hydrochloride Injection Revenue & Forecasts
5.2.1 By Application – Global Apomorphine Hydrochloride Injection Revenue, 2018-2023
5.2.2 By Application – Global Apomorphine Hydrochloride Injection Revenue, 2024-2029
5.2.3 By Application – Global Apomorphine Hydrochloride Injection Revenue Market Share, 2018-2029
5.3 By Application – Global Apomorphine Hydrochloride Injection Sales & Forecasts
5.3.1 By Application – Global Apomorphine Hydrochloride Injection Sales, 2018-2023
5.3.2 By Application – Global Apomorphine Hydrochloride Injection Sales, 2024-2029
5.3.3 By Application – Global Apomorphine Hydrochloride Injection Sales Market Share, 2018-2029
5.4 By Application – Global Apomorphine Hydrochloride Injection Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Apomorphine Hydrochloride Injection Market Size, 2022 & 2029
6.2 By Region – Global Apomorphine Hydrochloride Injection Revenue & Forecasts
6.2.1 By Region – Global Apomorphine Hydrochloride Injection Revenue, 2018-2023
6.2.2 By Region – Global Apomorphine Hydrochloride Injection Revenue, 2024-2029
6.2.3 By Region – Global Apomorphine Hydrochloride Injection Revenue Market Share, 2018-2029
6.3 By Region – Global Apomorphine Hydrochloride Injection Sales & Forecasts
6.3.1 By Region – Global Apomorphine Hydrochloride Injection Sales, 2018-2023
6.3.2 By Region – Global Apomorphine Hydrochloride Injection Sales, 2024-2029
6.3.3 By Region – Global Apomorphine Hydrochloride Injection Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Apomorphine Hydrochloride Injection Revenue, 2018-2029
6.4.2 By Country – North America Apomorphine Hydrochloride Injection Sales, 2018-2029
6.4.3 US Apomorphine Hydrochloride Injection Market Size, 2018-2029
6.4.4 Canada Apomorphine Hydrochloride Injection Market Size, 2018-2029
6.4.5 Mexico Apomorphine Hydrochloride Injection Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Apomorphine Hydrochloride Injection Revenue, 2018-2029
6.5.2 By Country – Europe Apomorphine Hydrochloride Injection Sales, 2018-2029
6.5.3 Germany Apomorphine Hydrochloride Injection Market Size, 2018-2029
6.5.4 France Apomorphine Hydrochloride Injection Market Size, 2018-2029
6.5.5 U.K. Apomorphine Hydrochloride Injection Market Size, 2018-2029
6.5.6 Italy Apomorphine Hydrochloride Injection Market Size, 2018-2029
6.5.7 Russia Apomorphine Hydrochloride Injection Market Size, 2018-2029
6.5.8 Nordic Countries Apomorphine Hydrochloride Injection Market Size, 2018-2029
6.5.9 Benelux Apomorphine Hydrochloride Injection Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Apomorphine Hydrochloride Injection Revenue, 2018-2029
6.6.2 By Region – Asia Apomorphine Hydrochloride Injection Sales, 2018-2029
6.6.3 China Apomorphine Hydrochloride Injection Market Size, 2018-2029
6.6.4 Japan Apomorphine Hydrochloride Injection Market Size, 2018-2029
6.6.5 South Korea Apomorphine Hydrochloride Injection Market Size, 2018-2029
6.6.6 Southeast Asia Apomorphine Hydrochloride Injection Market Size, 2018-2029
6.6.7 India Apomorphine Hydrochloride Injection Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Apomorphine Hydrochloride Injection Revenue, 2018-2029
6.7.2 By Country – South America Apomorphine Hydrochloride Injection Sales, 2018-2029
6.7.3 Brazil Apomorphine Hydrochloride Injection Market Size, 2018-2029
6.7.4 Argentina Apomorphine Hydrochloride Injection Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Apomorphine Hydrochloride Injection Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Apomorphine Hydrochloride Injection Sales, 2018-2029
6.8.3 Turkey Apomorphine Hydrochloride Injection Market Size, 2018-2029
6.8.4 Israel Apomorphine Hydrochloride Injection Market Size, 2018-2029
6.8.5 Saudi Arabia Apomorphine Hydrochloride Injection Market Size, 2018-2029
6.8.6 UAE Apomorphine Hydrochloride Injection Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Supernus Pharmaceuticals
7.1.1 Supernus Pharmaceuticals Company Summary
7.1.2 Supernus Pharmaceuticals Business Overview
7.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Major Product Offerings
7.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Sales and Revenue in Global (2018-2023)
7.1.5 Supernus Pharmaceuticals Key News & Latest Developments
7.2 Britannia Pharmaceuticals STADA
7.2.1 Britannia Pharmaceuticals STADA Company Summary
7.2.2 Britannia Pharmaceuticals STADA Business Overview
7.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Major Product Offerings
7.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Sales and Revenue in Global (2018-2023)
7.2.5 Britannia Pharmaceuticals STADA Key News & Latest Developments
7.3 Ever Pharma
7.3.1 Ever Pharma Company Summary
7.3.2 Ever Pharma Business Overview
7.3.3 Ever Pharma Apomorphine Hydrochloride Injection Major Product Offerings
7.3.4 Ever Pharma Apomorphine Hydrochloride Injection Sales and Revenue in Global (2018-2023)
7.3.5 Ever Pharma Key News & Latest Developments
7.4 Evolan Pharma AB (PharmSwed)
7.4.1 Evolan Pharma AB (PharmSwed) Company Summary
7.4.2 Evolan Pharma AB (PharmSwed) Business Overview
7.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Major Product Offerings
7.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Sales and Revenue in Global (2018-2023)
7.4.5 Evolan Pharma AB (PharmSwed) Key News & Latest Developments
8 Global Apomorphine Hydrochloride Injection Production Capacity, Analysis
8.1 Global Apomorphine Hydrochloride Injection Production Capacity, 2018-2029
8.2 Apomorphine Hydrochloride Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Apomorphine Hydrochloride Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Apomorphine Hydrochloride Injection Supply Chain Analysis
10.1 Apomorphine Hydrochloride Injection Industry Value Chain
10.2 Apomorphine Hydrochloride Injection Upstream Market
10.3 Apomorphine Hydrochloride Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Apomorphine Hydrochloride Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



★調査レポート[世界のアポモルヒネ塩酸塩注射液市場予測2023-2029:ペン型注射器、輸液ポンプ] (コード:MMG23JU5014)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のアポモルヒネ塩酸塩注射液市場予測2023-2029:ペン型注射器、輸液ポンプ]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆